Asiatic Laboratories Limited (DSE:ASIATICLAB)
Bangladesh · Delayed Price · Currency is BDT 54.50
+0.90 (1.68%)
At close: Jan 22, 2026
Asiatic Laboratories Revenue
Asiatic Laboratories had revenue of 741.36M BDT in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 2.24B. In the fiscal year ending June 30, 2025, Asiatic Laboratories had annual revenue of 1.77B with 27.45% growth.
Revenue (ttm)
2.24B
Revenue Growth
+27.45%
P/S Ratio
2.98
Revenue / Employee
3.04M
Employees
737
Market Cap
6.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.77B | 380.24M | 27.45% |
| Jun 30, 2024 | 1.39B | 95.98M | 7.44% |
| Jun 30, 2023 | 1.29B | -183.53M | -12.46% |
| Jun 30, 2022 | 1.47B | 21.53M | 1.48% |
| Jun 30, 2021 | 1.45B | 124.89M | 9.42% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The ACME Laboratories | 37.48B |
| The IBN SINA Pharmaceutical Industry | 12.84B |
| Beacon Pharmaceuticals | 11.58B |
| Navana Pharmaceuticals | 9.52B |
| Techno Drugs | 3.23B |
| Orion Pharma | 3.23B |
| Pharma Aids | 453.49M |
| Silco Pharmaceuticals | 428.63M |